Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 3, 2007, Pages 410-413

  Höybye, Charlotte ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adults; Long term GH treatment; PWS

Indexed keywords

GROWTH HORMONE;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG DOSE TITRATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; HYPERACTIVITY; LEAN BODY WEIGHT; LONG TERM CARE; MALE; OBSERVATIONAL STUDY; PRADER WILLI SYNDROME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BODY COMPOSITION; FEMALE; FOLLOW-UP STUDIES; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; MALE; PRADER-WILLI SYNDROME;

EID: 33947306439     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2006.00051.x     Document Type: Article

References (10)

1. Burman P, Ritzén EM, Lindgren AC. Endocrine dysfunction in Pradser Willi syndrome: a review with special reference to GH. Endocr Rev 2001; 22: 787-99.
2. Goldstone AP. Prader-Willi syndrome: advances in genetics, pathophysiology and treatmentTrends. Endocrinol Metab 2004; 15: 12-20.
3. Höybye C, Hilding A, Jacobsson H, Thorén M. Metabolic profile and body composition in adults with Prader Willi syndrome and severe obesity. J Clin Endocrinol Metab 2002; 87: 3590-97.
4. Höybye C, Frystyk J, Thorén M. The growth hormone-insulin-like growth factor axis in adult patients with Prader-Willi syndrome. Growth Horm IGF Res 2003; 13: 322-7.
5. Höybye C, Hilding A, Jacobsson H, Thorén M. Growth hormone treatment improves body composition in adults with Prader Willi syndrome. Clin Endocrinol (Oxf) 2003; 58: 653-61.
6. Tothill P, Avenell A, Love J, Reid DM. Comparisons between Hologic, Lunar and Norland dual X-ray absorptiometers and other techniques used for whole-body soft tissue measurements. Eur J Clin Nutr 1994; 48: 781-94.
7. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
8. Albareda M, Rodrigues-Espinosa J, Murugo M, de Leiva A, Corcoy R. Assesment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerence test. Diabetologia 2000; 43: 1507-11.
9. Bonora E, Kiechl S, Willeit J, Willet J, Obenhollenzer F, Egger G, et al. Prevalence of insulin resistance in metabolic disorders. The Bruneck Study. Diabetes 1998; 47: 1643-9.
10. Hilding A, Hall K, Wivall-Helleryd IL, Sääf M, Melin AL, Thorén M. Serum levels of insulin-like growth factor 1 in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 1999; 84: 2013-9.